RSR13: Effects on tumor oxygenation and response to therapy

Drug Development Research

Volumn 38, Issue 1, 1996, Pages 1-11

  Teicher, Beverly A ^a   Ara, Gulshan ^a   Emi, Yasunori ^a   Kakeji, Yoshihiro ^a   Ikebe, Masahiko ^a   Maehara, Yoshihiko ^a   Buxton, David ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Radiation therapy; RSR13; Tumor hypoxia; Tumor oxygenation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EFAPROXIRAL; FLUOROURACIL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; RADIATION DOSE; RAT; TISSUE OXYGENATION;

EID: 0029770717     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199605)38:1<1::AID-DDR1>3.0.CO;2-O     Document Type: Article

References (43)

1. Abraham DJ, Perutz MF, Phillips SEV (1983): Physiological and X-ray studies of potential antisickling agents. Proc Natl Acad Sci USA 80:324-328.
2. Abraham DJ, Wireko FC, Randad RS (1992): Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31:9141-9149.
3. Abraham DJ, Kister J, Joshi GS, Marden MC, Poyart C (1995): Intrinsic activity at the molecular level: E.J. Ariëns' concept visualized. J Mol Biol 248:845-855.
4. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ (1988): Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of therapy. Int J Radiat Oncol Biol Phys 14:831-838.
5. Grundy M, Vega L (1987): Fibric acids: Effects on lipids and lipoprotein metabolism. Am J Med 83:9.
6. Gullino PM (1975): In vivo utilization of oxygen and glucose by neoplastic tissue. Adv Exp Med Biol 75:521-536.
7. 2 by perfluorochemicals and carbogen. Int J Radiat Oncol Biol Phys 13:569-574.
8. Hayashi F, Tamura H, Watanabe T, Suga T (1995): Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. Cancer Lett 92:87-90.
9. Hilgard P (1984): Anticoagulants and tumor growth: Pharmacological considerations. In Nicolson GL, Milas L (eds): Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects. New York: Raven Press, pp 353-360.
10. Hirst DG, Wood PJ (1987): The influence of haemoglobin affinity for oxygen on tumour radiosensitivity. Br J Cancer 55:487-491.
11. Hirst DG, Wood PJ, Schwartz HC (1987): The modification of tumor radiosensitivity by antilipidemic drugs. Radiat Res 112: 164-172.
12. Jain RK (1988): Determinants of tumor blood flow: A review. Cancer Res 48:2641-2658.
13. Jani JP, Specht S, Stemmler N, Blanock K, Singh SV, Gupta V, Katoh A (1995): Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion Metastasis 13:314-324.
14. Khandelwal SR, Randad RS, Lin P-S, Meng H, Pittman RN, Kontos HA, Choi SC, Abraham DJ, Schmidt-Ullrich R (1993): Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265:H1450-H1453.
15. Pacot C, Petit M, Caira F, Rollin M, Behechti N, Grégoire S, Malki MC, Cavatz C, Moisant M, Moreau C, Thomas C, Descotes G, Gallas J-F, Deslex P, Althoff J, Zahnd J-P, Lhuguenot J-C, Latruffe N (1993): Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity compared to Zucker lean and Sprague-Dawley rats. Biol Cell 77:27-35.
16. Perutz MF, Poyart C (1983): Bezafibrate lowers oxygen affinity of haemoglobin. Lancet 2:881-882.
17. Rockwell S (1977): In vivo-in vitro tumor systems: New models for studying the response of tumors to therapy. Lab Anim Sci 27: 831-851.
18. Rockwell S (1978): Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT-6 mouse mammary tumor cells in vivo and in vitro. Br J Cancer 37:212-215.
19. Sevick EM, Jain RK (1989): Geometric resistance to blood flow in solid tumors perfused ex vivo: Effects of tumor size and perfusion pressure. Cancer Res 49:3513-3519.
20. Siemann DW, Macler LM (1986): Tumor radiosensitization through reductions in hemoglobin affinity. Int J Radiat Oncol Biol Phys 12:1295-1297.
21. Siemann DW, Hill RP, Bush RS (1978): Smoking: The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation. Int J Radiat Oncol Biol Phys 4:657-662.
22. Siemann DW, Hill RP, Bush RS, Chhabra P (1979): The in vivo radiation response of an experimental tumor: The effect of exposing tumor-bearing mice to reduced oxygen environment prior to but not during irradiation. Int J Radiat Oncol Biol Phys 5:61-68.
23. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Cancer Res 47:442-446.
24. Teicher BA (1995): Physiologic mechanisms of therapeutic resistance: Blood flow and hypoxia. In Fisher G (ed): Hematology/ Oncology Clinics of North America, Drug Resistance in Clinical Oncology and Hematology. Philadelphia: W.B. Saunders, pp 475-506.
25. Teicher BA, Herman TS (1993): Use of Fluosol-DA/oxygen breathing with radiation therapy and chemotherapy/radiation combinations. In John MJ, Flam MS, Legha SS, Phillips TL (eds): Chemoradiation: An Integrated Approach to Cancer Treatment. Philadelphia: Lea & Febiger, pp 140-158.
26. Teicher BA, Holden SA, Jacobs JL (1987): Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity. Cancer Res 47:513-518.
27. Teicher BA, Jacobs JL, Kelley MJ (1988): The influence of Fluosol®-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma. Invasion Metastasis 8:45-56.
28. Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E III (1990): Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. Semin Oncol 17:18-32.
29. Teicher BA, Herman TS, Frei E III (1992): Perfluorochemical emulsions: Oxygen breathing in radiation sensitization and chemotherapy modulation. In DeVita VTJ, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia: J.B. Lippincott, pp 39-59.
30. Teicher BA, Holden SA, Menon K, Hopkins RE, Gawryl MS (1993a): Effect of a hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents. Cancer Chemother Pharmacol 33:57-62.
31. Teicher BA, Schwartz GN, Alvarez Sotomayor E, Robinson MF, Dupuis NP, Menon K (1993b): Oxygenation of tumors by a hemoglobin solution. J Cancer Res Clin Oncol 120:85-90.
32. Teicher BA, Alvarez Sotomayor E, Dupuis N, Kusumoto T, Menon K (1994a): Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing. J Cancer Res Clin Oncol 120:593-598.
33. Teicher BA, Holden SA, Dupuis NP, Kusumoto T, Liu M, Liu F, Menon K (1994b): Oxygenation of the rat 9L gliosarcoma and the rat 13762 mammary carcinoma with various doses of a hemoglobin solution. Artif Cells Blood Subs Immob Biotech 22:827-833.
34. Teicher BA, Schwartz GN, Dupuis NP, Kusumoto T, Liu M, Liu F, Northey D (1994c): Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing. Artif Cells Blood Subs Immob Biotech 22:1369-1375.
35. Teicher BA, Ara G, Menon K, Schaub RG (1995a): In vivo studies with interleukin-12 alone and in combination with monocyte-colony stimulating factor and/or fractionated radiation therapy. Int J Cancer 65:80-84.
36. Teicher BA, Dupuis NP, Liu F, Robinson MF, Menon K (1995b): Administration of a hemoglobin solution decreases hypoxia and increases radiation response in a rat mammary carcinoma. Drug Dev Res 34:231-240.
37. Vaupel P (1993): Oxygenation of solid tumors. In Teicher BA (eds): Drug Resistance in Oncology. New York: Marcel Dekker, pp 53-85.
38. Vaupel P, Frinak S, Bicher HI (1981): Heterogeneous oxygen partial pressure and pH distribution of C3H mouse mammary adenocarcinoma. Cancer Res 41:2008-2013.
39. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F (1987): Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47:3496-3503.
40. Vaupel P, Kallinowski F, Okunieff P (1989): Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
41. Vitu-Loas L, Thomas C, Chavaudra N, Guichard M (1993): Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injection. Radiother Oncol 27:149-155.
42. 2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension. Am J Physiol 265:H1439-H1443.
43. Wooton R (1984): Analysis of the effect of bezafibrate on the oxygen dissociation curve of human hemoglobin. FEBS Lett 171:187-191.